Literature DB >> 931480

Gastric bezoar formation secondary to gastroparesis diabeticorum.

P G Brady, R Richardson.   

Abstract

Diabetic autonomic neuropathy may result in delayed gastric emptying and gastric retention. A case of gastric phytobezoar formation that was secondary to diabetic autonomic neuropathy is reported. Greatly impaired gastric emptying was documented in this case by administration of a radiolabelled meal. Parenteral metoclopramide hydrochloride completely corrected the patient's gastric motility disturbance.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 931480

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


  6 in total

1.  Gastric phytobezoar: treatment using meat tenderizer.

Authors:  A J Dwivedi; F Chahin; S Agrawal; J Patel; M Khalid; Y Lakra
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

2.  Small bowel phytobezoar mimicking presentation of Crohn's disease.

Authors:  A Prior; D F Martin; P J Whorwell
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

Review 3.  Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists.

Authors:  Paul Kuo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis.

Authors:  S G Desautels; W R Hutson; P E Christian; J G Moore; F L Datz
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

Review 5.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

6.  Temporary Endoscopic Stimulation in Gastroparesis-like Syndrome.

Authors:  Sanjeev Singh; Jeff McCrary; Archana Kedar; Stephen Weeks; Brian Beauerle; Andrew Weeks; Omer Endashaw; Chris Lahr; Warren Starkebaum; Thomas Abell
Journal:  J Neurogastroenterol Motil       Date:  2015-10-01       Impact factor: 4.924
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.